Lupin Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets.".